A new endometriosis treatment developed by a UCLA alumnus will enter clinical trials after receiving Food and Drug Administration clearance in March. EndoCyclic Therapeutics, a biopharmaceutical company founded by Tanya Petrossian, received approval from the FDA to test ENDO-205 – a non-hormonal treatment for endometriosis – on humans. Read more...






